The FDA has just cleared Aspect Imaging‘s Embrace Neonatal MRI System, the first dedicated neonatal MRI system to receive a regulatory green light in the U.S. It’s intended to be used to image the head and brain, and to remain inside of neonatal intensive care units (NICU). Currently, these fragile little patients have to be […]
Uncategorized
Voretigene neparvovec receives rare pediatric disease designation from FDA
by Healio ophthalmology •
The FDA offices of Orphan Products Development and Pediatric Therapeutics have designated voretigene neparvovec as a drug for a rare pediatric disease, according to a Spark Therapeutics press release.Voretigene neparvovec, which will be marketed under …
Uncategorized
Akorn shareholders approve Fresenius Kabi merger
by Healio ophthalmology •
Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release.Fresenius Kabi announced in April that it would acquire the company for $4.3 billion, or $34 per share. The agreement allowed for $450 million in debt to…
Business, News
Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017
by Business Wire •
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced that it will report its second quarter 2017 financial and operating results on Wednesday, July 26, 2017.
Uncategorized
Amniotic membrane transplantation adds to benefits of antibiotics in bacterial keratitis
by Healio ophthalmology •
The combination of amniotic membrane transplantation and antibiotic therapy leads to significantly better results than antibiotic therapy alone in eyes with bacterial keratitis, according to a study.At Farabi Eye Hospital in Tehran, Iran, 49 eyes of 49…
Uncategorized
MedOp Health Confirms Claims on Label
by Business Wire •
OLDSMAR, Fla.–(BUSINESS WIRE)–MedOp Health announces that it has proven that the new MaxiVision® Meso Plus Formula DOES CONTAIN ALL THE LEVEL OF CAROTENOIDS CLAIMED ON THE LABEL.
Uncategorized
Second Sight to Discuss Second Quarter 2017 Financial Results on August 1, 2017 Conference Call
by Business Wire •
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, will release its second quar…
News
New MRI Probe Highlights Fibrogenesis to Help Track Scar Formation Noninvasively
by Medgadged •
Tissue injuries often result in fibrogenesis, a process involving the development of an extracellular matrix that results in scars. While it can be viewed on the exterior of the body, currently there are no noninvasive methods to track the progress of fibrogenesis within the body’s interior. A team of researchers at Harvard Medical Schoo (Read more...)
Uncategorized
NIH awards $1.9 million grant to study bacterial endophthalmitis
by Healio ophthalmology •
The National Eye Institute of the National Institutes of Health has awarded a $1.9 million grant to a Wayne State University School of Medicine researcher, according to a press release from the school. Ashok Kumar, PhD, assistant professor of opht…
News
Stryker’s MultiGen 2RF Generator for Facet Joint Ablations Cleared by FDA
by Medgadged •
Stryker, a company best known for orthopedic devices, won FDA clearance to introduce its MultiGen 2 RF Generator in the U.S. The device is used to treat pain deriving from facet joints in the spine by delivering radiofrequency energy that ablates targeted tissues. Compared to the previous version of the device, Stryker claims that the MultiGen (Read more...)